Intended for healthcare professionals

CCBYNC Open access
Research

Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis

BMJ 2018; 361 doi: https://doi.org/10.1136/bmj.k2031 (Published 24 May 2018) Cite this as: BMJ 2018;361:k2031